Kelly Shi
Stock Analyst at Jefferies
(3.21)
# 1,048
Out of 5,152 analysts
34
Total ratings
45.45%
Success rate
17.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $8.96 | +0.45% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $83.52 | +46.07% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $63.33 | +21.59% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $143.57 | +3.09% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $37.46 | -25.25% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $14.94 | +194.51% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $6.15 | +143.90% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $8.53 | +509.61% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $5.63 | +148.89% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $26.34 | -27.87% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $174 → $196 | $237.35 | -17.42% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $5.74 | +265.85% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $21.58 | +71.46% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.35 | +155.32% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $97.33 | -16.78% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $25.25 | +38.61% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.18 | +1,032.08% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $18.02 | -11.21% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $17.95 | +11.42% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $7.46 | +5,690.88% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $13.85 | +275.45% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.46 | +997.56% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $3.02 | +992.72% | 1 | Mar 8, 2021 |
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $8.96
Upside: +0.45%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $83.52
Upside: +46.07%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $63.33
Upside: +21.59%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $143.57
Upside: +3.09%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $37.46
Upside: -25.25%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $14.94
Upside: +194.51%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $6.15
Upside: +143.90%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $8.53
Upside: +509.61%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $5.63
Upside: +148.89%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $26.34
Upside: -27.87%
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $237.35
Upside: -17.42%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $5.74
Upside: +265.85%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $21.58
Upside: +71.46%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.35
Upside: +155.32%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $97.33
Upside: -16.78%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $25.25
Upside: +38.61%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $3.18
Upside: +1,032.08%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $18.02
Upside: -11.21%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $17.95
Upside: +11.42%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $7.46
Upside: +5,690.88%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $13.85
Upside: +275.45%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.46
Upside: +997.56%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $3.02
Upside: +992.72%